ArticleIDCases2025
Lupus vorax: A rare case of facial tuberculosis in a patient with Noonan syndrome.
Article in IDCases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lupus vorax is a rare, aggressive ulcerative variant of lupus vulgaris, the most common form of cutaneous tuberculosis, characterized by rapid tissue destruction, extensive scarring, and potential disfigurement. We report the case of a 30-year-old man with Noonan syndrome who presented with chronic facial ulcerations initially suspected to represent pyoderma gangrenosum (PG). The lesion, involving the upper lip, nasal alae, and left eyelid region, had been present for two years with progressive worsening. Initial histology suggested PG or granulomatosis with polyangiitis; however, PCR and culture from a subsequent biopsy confirmed a multisensitive Mycobacterium tuberculosis strain. Quadruple anti-tubercular therapy led to complete lesion resolution within nine months, leaving residual scarring and functional sequelae. This case highlights the diagnostic challenge of differentiating PG from infectious mimickers, the need for multiple diagnostic modalities in atypical presentations, and the importance of considering rare etiologies, even in patients with genetic disorders potentially associated with immune dysregulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.